Literature DB >> 20427309

Validation of Hospital Administrative Dataset for adverse event screening.

Sandra Verelst1, Jessica Jacques, Koen Van den Heede, Pierre Gillet, Philippe Kolh, Arthur Vleugels, Walter Sermeus.   

Abstract

OBJECTIVE: To assess whether the Belgian Hospital Discharge Dataset (B-HDDS) is a valid source for the detection of adverse events in acute hospitals. DESIGN, SETTING AND PARTICIPANTS: Retrospective review of 1515 patient records in eight acute Belgian hospitals for the year 2005. MAIN OUTCOME MEASURES: Predictive value of the B-HDDS and medical record reviews and degree of correspondence between the B-HDDS and medical record reviews for five indicators: pressure ulcer, postoperative pulmonary embolism or deep vein thrombosis, postoperative sepsis, ventilator-associated pneumonia and postoperative wound infection.
RESULTS: Postoperative wound infection received the highest positive predictive value (62.3%), whereas postoperative sepsis and ventilator-associated pneumonia were rated as only 44.2% and 29.9% respectively. Excluding present on admission from the screening substantially decreased the positive predictive value of pressure ulcer from 74.5% to 54.3%, as pressure ulcers present on admission were responsible for more B-HDDS-medical record mismatches than any other indicator. Over half (56.8%) of false-positive cases for postoperative sepsis were due to a lack of specificity of the ICD-9-CM code, whereas in 58.6% of false-positive cases for ventilator-associated pneumonia, clinical criteria appeared to be too stringent.
CONCLUSIONS: The B-HDDS has the potential to accurately detect some but not all adverse events. Adding a code 'present on admission' and improving the ICD-9-CM codes might already partially improve the correspondence between the B-HDDS and the medical record review.

Entities:  

Mesh:

Year:  2010        PMID: 20427309     DOI: 10.1136/qshc.2009.034306

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  7 in total

1.  Validity and Reliability of Administrative Coded Data for the Identification of Hospital-Acquired Infections: An Updated Systematic Review with Meta-Analysis and Meta-Regression Analysis.

Authors:  Olga Redondo-González; José María Tenías; Ángel Arias; Alfredo J Lucendo
Journal:  Health Serv Res       Date:  2017-04-11       Impact factor: 3.402

Review 2.  Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review.

Authors:  Maaike S M van Mourik; Pleun Joppe van Duijn; Karel G M Moons; Marc J M Bonten; Grace M Lee
Journal:  BMJ Open       Date:  2015-08-27       Impact factor: 2.692

3.  Validating administrative data for the detection of adverse events in older hospitalized patients.

Authors:  Stacy Ackroyd-Stolarz; Susan K Bowles; Lorri Giffin
Journal:  Drug Healthc Patient Saf       Date:  2014-08-13

4.  Methods for evaluating adverse drug event preventability in emergency department patients.

Authors:  Stephanie A Woo; Amber Cragg; Maeve E Wickham; David Peddie; Ellen Balka; Frank Scheuermeyer; Diane Villanyi; Corinne M Hohl
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

5.  Predicting ventilator-associated pneumonia with machine learning.

Authors:  Christine Giang; Jacob Calvert; Keyvan Rahmani; Gina Barnes; Anna Siefkas; Abigail Green-Saxena; Jana Hoffman; Qingqing Mao; Ritankar Das
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

6.  Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study.

Authors:  Corinne M Hohl; Lisa Kuramoto; Eugenia Yu; Basia Rogula; Jürgen Stausberg; Boris Sobolev
Journal:  BMC Health Serv Res       Date:  2013-11-12       Impact factor: 2.655

7.  Identifying Adverse Events Using International Classification of Diseases, Tenth Revision Y Codes in Korea: A Cross-sectional Study.

Authors:  Minsu Ock; Hwa Jung Kim; Bomin Jeon; Ye-Jee Kim; Hyun Mi Ryu; Moo-Song Lee
Journal:  J Prev Med Public Health       Date:  2018-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.